Immune-engineered device targets chemo-resistant lymphoma
Non-Hodgkin lymphoma, a cancer that is diagnosed in the U.S. more than 70,000 times annually, arises from overly proliferating immune cells within the body's lymph nodes, which are connected to a network of lymph vessels ...
Apr 12, 2018
0
38